EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease






Clinical Science 73(4): 361-364

Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease

1. Colonic mucosa from 19 patients with ulcerative colitis, eight with Crohn's disease and 14 controls were analysed for arachidonic acid (C20:4), linoleic acid (C18:2), oleic acid (C18:1), stearic acid (C18:0) and palmitic acid (C16:0). 2. Gas-liquid chromatography of lipid extracts showed that arachidonic acid was significantly higher in ulcerative colitis (19 +/- 4) and Crohn's disease (20 +/- 3) than in controls (13 +/- 5 micrograms/mg of protein) (means +/- SD). Neither the degree of inflammation nor treatment with sulphasalazine or prednisolone appeared to influence the fatty acid concentrations. 3. Seventy-five to ninety-five per cent of the arachidonic acid was found in the phospholipid fraction after separation by thin-layer chromatography. There were no significant changes in the concentrations of the other fatty acids measured, although oleic acid was lower in inflammatory bowel disease. The ratios of oleic acid to stearic acid and to palmitic acid were lower in inflammatory bowel disease. 4. The alteration in the fatty acid profile may partly explain the increased synthesis of eicosanoids in colonic mucosa in inflammatory bowel disease.

(PDF same-day service: $19.90)

Accession: 001615207

PMID: 3665357

DOI: 10.1042/cs0730361



Related references

Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut 28(8): 1002-1007, 1987

Phospholipid turnover in the inflamed intestinal mucosa: Arachidonic acid-rich phosphatidyl/plasmenyl-ethanolamine in the mucosa in inflammatory bowel disease. Journal of Gastroenterology 34(1): 46-53, 1999

Increased production of stromelysin by inflamed colonic mucosa in inflammatory bowel disease. Gastroenterology 114(4 PART 2): A1027, April 15, 1998

Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease. Digestive Diseases and Sciences 48(10): 2083-2090, 2003

Enhanced expression of interleukin 8 mrna and increased il 8 production by colonic mucosa in inflammatory bowel disease. Gastroenterology 102(4 PART 2): A642, 1992

Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clinical and Experimental Immunology 151(1): 34-41, 2007

Expression of thromboxane synthase is increased in lamina proprial cells of inflamed colonic mucosa in inflammatory bowel disease. Gut 44(SUPPL 1): A32, April, 1999

Expression of thromboxane synthase is increased in lamina proprial cells of inflamed colonic mucosa in patients with inflammatory bowel disease. Gastroenterology 116(4 PART 2): A802, April, 1999

Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathology International 44(8): 624-634, 1994

Changes in neuropeptide-containing nerves in human colonic mucosa in inflammatory bowel disease. Pathology International 44(8): 624-634, 1994